Annual Income Tax
$9.84 M
-$31.39 M-76.13%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual income tax is currently $9.84 million, with the most recent change of -$31.39 million (-76.13%) on 31 December 2023. During the last 3 years, it has risen by +$15.15 million (+285.47%). LGND annual income tax is now -94.12% below its all-time high of $167.34 million, reached on 31 December 2019.LGND Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Income Tax
$833.00 K
+$14.31 M+106.18%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly income tax is currently $833.00 thousand, with the most recent change of +$14.31 million (+106.18%) on 30 September 2024. Over the past year, it has increased by +$2.70 million (+144.52%). LGND quarterly income tax is now -99.53% below its all-time high of $176.38 million, reached on 31 March 2019.LGND Quarterly Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Income Tax
$13.57 M
+$2.70 M+24.88%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated TTM income tax is currently $13.57 million, with the most recent change of +$2.70 million (+24.88%) on 30 September 2024. Over the past year, it has dropped by -$36.03 million (-72.64%). LGND TTM income tax is now -93.09% below its all-time high of $196.35 million, reached on 31 March 2019.LGND TTM Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Income Tax Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.1% | +144.5% | -72.6% |
| 3 y3 years | +285.5% | -45.8% | +262.1% |
| 5 y5 years | -67.2% | +118.0% | -91.2% |
LGND Income Tax High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -76.1% | +285.5% | -97.8% | +106.2% | -75.0% | +262.1% |
| 5 y | 5 years | -94.1% | +285.5% | -97.8% | +106.2% | -91.9% | +188.6% |
| alltime | all time | -94.1% | +105.1% | -99.5% | +100.4% | -93.1% | +107.0% |
Ligand Pharmaceuticals Incorporated Income Tax History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $833.00 K(-106.2%) | $13.57 M(+24.9%) |
| June 2024 | - | -$13.48 M(-149.4%) | $10.87 M(-56.9%) |
| Mar 2024 | - | $27.31 M(-2603.0%) | $25.23 M(+156.3%) |
| Dec 2023 | $9.84 M(-76.1%) | -$1.09 M(-41.7%) | $9.84 M(-80.2%) |
| Sept 2023 | - | -$1.87 M(-312.4%) | $49.61 M(-8.5%) |
| June 2023 | - | $881.00 K(-92.6%) | $54.19 M(+9.8%) |
| Mar 2023 | - | $11.92 M(-69.2%) | $49.37 M(+19.7%) |
| Dec 2022 | $41.23 M(-1094.0%) | $38.67 M(+1327.6%) | $41.23 M(+521.1%) |
| Sept 2022 | - | $2.71 M(-168.8%) | $6.64 M(+21.5%) |
| June 2022 | - | -$3.94 M(-204.0%) | $5.46 M(-54.4%) |
| Mar 2022 | - | $3.79 M(-7.3%) | $11.98 M(-388.8%) |
| Dec 2021 | -$4.15 M(-21.8%) | $4.08 M(+165.8%) | -$4.15 M(-50.5%) |
| Sept 2021 | - | $1.54 M(-40.4%) | -$8.37 M(-43.5%) |
| June 2021 | - | $2.58 M(-120.9%) | -$14.82 M(+30.4%) |
| Mar 2021 | - | -$12.34 M(+8470.8%) | -$11.36 M(+114.2%) |
| Dec 2020 | -$5.31 M(-103.2%) | -$144.00 K(-97.1%) | -$5.31 M(-11.2%) |
| Sept 2020 | - | -$4.91 M(-181.4%) | -$5.97 M(+5.1%) |
| June 2020 | - | $6.03 M(-196.0%) | -$5.68 M(-62.9%) |
| Mar 2020 | - | -$6.28 M(+675.8%) | -$15.32 M(-109.2%) |
| Dec 2019 | $167.34 M(+457.6%) | -$810.00 K(-82.5%) | $167.34 M(+8.8%) |
| Sept 2019 | - | -$4.62 M(+28.0%) | $153.84 M(-9.7%) |
| June 2019 | - | -$3.61 M(-102.0%) | $170.32 M(-13.3%) |
| Mar 2019 | - | $176.38 M(-1332.8%) | $196.35 M(+554.3%) |
| Dec 2018 | $30.01 M(-32.8%) | -$14.31 M(-220.6%) | $30.01 M(-63.4%) |
| Sept 2018 | - | $11.86 M(-47.1%) | $81.99 M(+11.1%) |
| June 2018 | - | $22.42 M(+123.5%) | $73.77 M(+37.6%) |
| Mar 2018 | - | $10.03 M(-73.4%) | $53.59 M(+20.0%) |
| Dec 2017 | $44.67 M(+332.6%) | $37.67 M(+933.6%) | $44.68 M(+157.4%) |
| Sept 2017 | - | $3.65 M(+62.6%) | $17.36 M(+25.1%) |
| June 2017 | - | $2.24 M(+101.3%) | $13.87 M(+79.0%) |
| Mar 2017 | - | $1.11 M(-89.2%) | $7.75 M(-25.0%) |
| Dec 2016 | $10.33 M(-105.4%) | $10.36 M(+6371.9%) | $10.33 M(-2012.6%) |
| Sept 2016 | - | $160.00 K(-104.1%) | -$540.00 K(-99.7%) |
| June 2016 | - | -$3.88 M(-205.1%) | -$192.58 M(+2.2%) |
| Mar 2016 | - | $3.69 M(-820.1%) | -$188.44 M(-1.9%) |
| Dec 2015 | -$192.12 M(<-9900.0%) | -$513.00 K(-99.7%) | -$192.11 M(+0.4%) |
| Sept 2015 | - | -$191.88 M(<-9900.0%) | -$191.32 M(<-9900.0%) |
| June 2015 | - | $265.00 K(+1666.7%) | $683.00 K(+84.1%) |
| Mar 2015 | - | $15.00 K(-94.6%) | $371.00 K(-9.3%) |
| Dec 2014 | $410.00 K | $279.00 K(+125.0%) | $409.00 K(+53.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $124.00 K(-363.8%) | $267.00 K(+31.5%) |
| June 2014 | - | -$47.00 K(-188.7%) | $203.00 K(-43.6%) |
| Mar 2014 | - | $53.00 K(-61.3%) | $360.00 K(-3.5%) |
| Dec 2013 | $374.00 K(-131.4%) | $137.00 K(+128.3%) | $373.00 K(-126.6%) |
| Sept 2013 | - | $60.00 K(-45.5%) | -$1.40 M(+6.2%) |
| June 2013 | - | $110.00 K(+66.7%) | -$1.32 M(+20.9%) |
| Mar 2013 | - | $66.00 K(-104.0%) | -$1.09 M(-8.5%) |
| Dec 2012 | -$1.19 M(-91.0%) | -$1.64 M(-1252.1%) | -$1.19 M(-259.4%) |
| Sept 2012 | - | $142.00 K(-58.0%) | $747.00 K(+19.1%) |
| June 2012 | - | $338.00 K(-1065.7%) | $627.00 K(+45.8%) |
| Mar 2012 | - | -$35.00 K(-111.6%) | $430.00 K(-103.2%) |
| Dec 2011 | -$13.27 M(+407.1%) | $302.00 K(+1272.7%) | -$13.27 M(-24.2%) |
| Sept 2011 | - | $22.00 K(-84.4%) | -$17.50 M(+2.3%) |
| June 2011 | - | $141.00 K(-101.0%) | -$17.11 M(+2.9%) |
| Mar 2011 | - | -$13.73 M(+248.9%) | -$16.62 M(+535.1%) |
| Dec 2010 | -$2.62 M(+70.5%) | -$3.94 M(-1039.1%) | -$2.62 M(+1106.0%) |
| Sept 2010 | - | $419.00 K(-33.0%) | -$217.00 K(-65.9%) |
| June 2010 | - | $625.00 K(+128.1%) | -$636.00 K(-49.6%) |
| Mar 2010 | - | $274.00 K(-117.9%) | -$1.26 M(-17.9%) |
| Dec 2009 | -$1.53 M(+2690.9%) | -$1.53 M(<-9900.0%) | -$1.53 M(+556.0%) |
| Sept 2009 | - | $0.00(0.0%) | -$234.00 K(-108.5%) |
| June 2009 | - | $0.00(0.0%) | $2.76 M(+59.7%) |
| Mar 2009 | - | $0.00(-100.0%) | $1.73 M(-3238.2%) |
| Dec 2008 | -$55.00 K(-99.7%) | -$234.00 K(-107.8%) | -$55.00 K(-98.0%) |
| Sept 2008 | - | $2.99 M(-390.3%) | -$2.74 M(-66.1%) |
| June 2008 | - | -$1.03 M(-42.2%) | -$8.09 M(-28.3%) |
| Mar 2008 | - | -$1.78 M(-39.0%) | -$11.28 M(-39.6%) |
| Dec 2007 | -$18.70 M(-0.6%) | -$2.92 M(+23.6%) | -$18.70 M(+18.5%) |
| Sept 2007 | - | -$2.36 M(-44.1%) | -$15.78 M(+17.6%) |
| June 2007 | - | -$4.22 M(-54.0%) | -$13.42 M(+46.0%) |
| Mar 2007 | - | -$9.19 M(<-9900.0%) | -$9.19 M(-5151.6%) |
| Dec 2006 | -$18.81 M(+198.1%) | - | - |
| Dec 2005 | -$6.31 M(-3624.6%) | - | - |
| June 2005 | - | $17.00 K(-15.0%) | $182.00 K(-0.5%) |
| Mar 2005 | - | $20.00 K(-85.9%) | $183.00 K(+2.2%) |
| Dec 2004 | $179.00 K(+219.6%) | $142.00 K(+4633.3%) | $179.00 K(+383.8%) |
| Sept 2004 | - | $3000.00(-83.3%) | $37.00 K(+8.8%) |
| June 2004 | - | $18.00 K(+12.5%) | $34.00 K(+112.5%) |
| Mar 2004 | - | $16.00 K | $16.00 K |
| Dec 2003 | $56.00 K(+27.3%) | - | - |
| Dec 2002 | $44.00 K | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual income tax?
- What is the all time high annual income tax for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual income tax year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly income tax?
- What is the all time high quarterly income tax for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly income tax year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM income tax?
- What is the all time high TTM income tax for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM income tax year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual income tax?
The current annual income tax of LGND is $9.84 M
What is the all time high annual income tax for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual income tax is $167.34 M
What is Ligand Pharmaceuticals Incorporated annual income tax year-on-year change?
Over the past year, LGND annual income tax has changed by -$31.39 M (-76.13%)
What is Ligand Pharmaceuticals Incorporated quarterly income tax?
The current quarterly income tax of LGND is $833.00 K
What is the all time high quarterly income tax for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly income tax is $176.38 M
What is Ligand Pharmaceuticals Incorporated quarterly income tax year-on-year change?
Over the past year, LGND quarterly income tax has changed by +$2.70 M (+144.52%)
What is Ligand Pharmaceuticals Incorporated TTM income tax?
The current TTM income tax of LGND is $13.57 M
What is the all time high TTM income tax for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM income tax is $196.35 M
What is Ligand Pharmaceuticals Incorporated TTM income tax year-on-year change?
Over the past year, LGND TTM income tax has changed by -$36.03 M (-72.64%)